AM-IA brings together news, research papers and applications relating to artificial intelligence published around the world into a single feed — and makes them available in your European language at the click of a button.
Scroll to browse · Click to filter
In the spring of 2027, five new pathologies will join the system that remunerates technology providers on the results obtained in patients, and not on the volume of procedures.
Powerful Medical's algorithm targets complete coronary occlusions that are not obvious from the tracing, in order to refer patients to a cath room faster.
More than a thousand pages obtained by the Electronic Frontier Foundation document the rushed launch of the WISeR model, and the subsequent delays in care in six states.
James Deardorff of UCSF cautions that the statistical performance of a prognostic model says nothing about what is done with it at the bedside of an elderly patient.
The system allows some manufacturers to market their products in real conditions before full approval, in exchange for close supervision by the agency.
At Adventist Health, machine learning had reported opioid diversions from a temporary nurse. Alerts went unanswered.
In STAT, Arya Rao and Marc Succi argue that announcements about AI that goes beyond doctors have mainly fed private medicine outside the walls, backed by commercial interests.
The additional payments for new technologies, paid two to three years after market entry, have never benefited as many AI tools as they did in 2026.
The meeting, set for Sept. 23, marks the first time an FDA panel has reviewed a multi-cancer early detection test.
In the era of widespread clinical AI, the US agency is tightening the criteria under which a device can qualify for its fast-track procedure.